Written by The global tissue banking market is witnessing significant expansion, supported by the growing geriatric population, rising prevalence of cancer, cardiovascular disorders, diabetes and other chronic diseases, and increasing awareness of tissue donation and preservation. The market was valued at US$1,056.4 million in 2017 and was projected to reach nearly US$2,903.3 million by 2026, representing a CAGR of approximately 12.0% between 2018 and 2026. Growing demand for human tissues in therapeutic procedures, research and drug discovery is encouraging healthcare institutions, research organizations and tissue banks to invest in advanced preservation, storage and quality-control technologies. The increasing prevalence of cardiovascular diseases is particularly relevant to demand for tissues such as heart valves and corneas, while the expanding use of umbilical cord blood preservation is creating additional opportunities.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14681
Market Overview
Technological innovation remains a major growth factor for the tissue banking industry. The development of ultra-low-temperature and automated freezer systems has improved the ability of tissue banks and research institutions to preserve large volumes of biological samples under controlled conditions. Advances in cryopreservation, thawing, monitoring and quality-control systems are supporting greater operational efficiency and sample integrity. At the same time, government initiatives aimed at improving tissue donation infrastructure, strategic collaborations, mergers and acquisitions, and the broader adoption of human tissue in therapeutic and research applications are contributing to market development. However, stringent regulatory requirements surrounding tissue collection, processing, storage and transplantation continue to create compliance challenges for market participants.
Market Size and Growth
The market’s projected growth reflects increasing healthcare expenditure and the expanding clinical and research applications of preserved human tissue. The therapeutic use of tissues remains a key contributor, particularly as healthcare systems address the growing burden of chronic diseases. Cardiovascular disease, cancer and other long-term conditions are increasing the requirement for tissue-based interventions and related preservation infrastructure. Increasing awareness about tissue donation, coupled with improvements in storage technologies, is also expected to support long-term demand. Growth in biobanking, personalized medicine and biomedical research further broadens the addressable market for tissue-storage and preservation solutions.
Market Segmentation
The global tissue banking market can be segmented by product, tissue type, application and geography. By product, the market comprises equipment and media & consumables, with equipment further divided into cryopreservation equipment, thawing equipment, quality-control equipment and other systems. Equipment is expected to remain an important segment as tissue banks modernize storage infrastructure and adopt automated solutions. By tissue type, the market includes heart valves, cornea, bone, skin, and brain & spinal cord. Heart valves and corneas represented prominent tissue categories, supported by demand associated with cardiovascular and ophthalmic conditions. By application, the market encompasses therapeutics, cosmetics, research & development, drug discovery and other applications, with therapeutics representing a major area of demand.
Regional Analysis
North America represented the largest regional market in the cited 2017 assessment, accounting for approximately 45.0% of global revenue. High healthcare expenditure, advanced healthcare infrastructure, tissue-donation awareness and the prevalence of cardiovascular diseases supported regional demand. Europe is expected to benefit from technological developments, product launches, collaborations and industry consolidation. Asia Pacific, particularly China and India, offers substantial growth opportunities because of expanding healthcare infrastructure, increasing disease burden and new product introductions. Latin America and the Middle East & Africa are also expected to develop as tissue banking infrastructure expands and the use of allograft products increases.
Competitive Landscape
The competitive landscape includes established healthcare, laboratory technology and biopreservation companies such as Thermo Fisher Scientific, Brooks Automation, VWR, BioLife Solutions, PHC Corporation, Custom Biogenic Systems, Bluechiip Limited, Merck KGaA, Beckman Coulter and Hamilton Company. Companies are pursuing product development, geographic expansion, strategic partnerships, acquisitions and broader product portfolios to strengthen their positions across the tissue banking ecosystem.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:Â
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453